Hopefully, this multidisciplinary consensus may contribute to expanding our knowledge of the practical use of GLP1-RAs, providing useful tools for physicians to use when managing people with T2D or overweight/obesity with this therapeutic class. The gene discussed is GLP1R; the disease is Obesity.